(Q72585093)
Statements
Genetically engineered deglycosylation of the variable domain increases the affinity of an anti-CD33 monoclonal antibody (English)
M S Co
D A Scheinberg
N M Avdalovic
K McGraw
M Vasquez
P C Caron
1 October 1993